title: [Buruli ulcer in Togo: 21 cases].
authors.forename: B
authors.initials: B
authors.lastname: Songné
authors.forename: B
authors.initials: B
authors.lastname: Abété
authors.forename: M
authors.initials: M
authors.lastname: Scotté
authors.forename: N
authors.initials: N
authors.lastname: Tignokpa
authors.forename: P
authors.initials: P
authors.lastname: Valenti
authors.forename: K L
authors.initials: KL
authors.lastname: Tchangaï-Walla
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage; D000995:Antitubercular Agents / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D017291:Clarithromycin / Q000008:administration & dosage; D003475:Curettage; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004977:Ethambutol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy / Q000453:epidemiology* / Q000601:surgery; D019911:Mycobacterium ulcerans; D012293:Rifampin / Q000008:administration & dosage; D016038:Skin Transplantation; D013997:Time Factors; D014037:Togo / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D004977:Ethambutol; D017291:Clarithromycin; D012293:Rifampin